» Articles » PMID: 28094201

Diagnosing Urogenital Schistosomiasis: Dealing with Diminishing Returns

Overview
Specialty Parasitology
Date 2017 Jan 18
PMID 28094201
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Urogenital schistosomiasis, caused by Schistosoma haematobium, is the most prevalent form of schistosomiasis affecting humans, and can result in severe bladder, kidney, ureteral, and genital pathologies. Chronic infection with S. haematobium has been linked with bladder cancer and increased risk for HIV infection. As mass drug administration with praziquantel increases in an attempt to transition from control to elimination of schistosomiasis, the need for updated, more sensitive diagnostic tools becomes more apparent, especially for use in areas of low infection intensity and for individuals with light infections. Here, we review established and investigational diagnostic tests utilized for urogenital schistosomiasis, highlighting new insights and recent advances.

Citing Articles

Detection and analysis of Serpin and RP26 specific antibodies for monitoring Schistosoma haematobium transmission.

Kokubo-Tanaka M, Kildemoes A, Chadeka E, Cheruiyot B, Moriyasu T, Sassa M PLoS Negl Trop Dis. 2025; 19(1):e0012813.

PMID: 39854314 PMC: 11759395. DOI: 10.1371/journal.pntd.0012813.


Efficacy of Praziquantel in Treating Infection Among Ethiopian Children.

Fok L, Brett-Major D, Erko B, Linville J, Dai H, Negash Y Biomedicines. 2024; 12(11).

PMID: 39595029 PMC: 11592285. DOI: 10.3390/biomedicines12112463.


Schistosomiasis infections in South African pregnant women: A review.

Bengu M, Dorsamy V, Moodley J S Afr J Infect Dis. 2024; 35(1):171.

PMID: 39380900 PMC: 11459292. DOI: 10.4102/sajid.v35i1.171.


Refining the Schistosoma haematobium recombinase polymerase amplification (Sh-RPA) assay: moving towards point-of-care use in endemic settings.

Donnelly O, Mesquita S, Archer J, Ali S, Bartonicek Z, Lugli E Parasit Vectors. 2024; 17(1):321.

PMID: 39068490 PMC: 11283713. DOI: 10.1186/s13071-024-06380-9.


A comprehensive exploration of schistosomiasis: Global impact, molecular characterization, drug discovery, artificial intelligence and future prospects.

Ekloh W, Asafu-Adjaye A, Tawiah-Mensah C, Ayivi-Tosuh S, Quartey N, Aiduenu A Heliyon. 2024; 10(12):e33070.

PMID: 38988508 PMC: 11234110. DOI: 10.1016/j.heliyon.2024.e33070.